Importantly, the expression of tyrosine metabolizing enzymes was able to discriminate the extent to which clinical features including grade, IDH status, 1p19q status, and MGMT, suggesting their potential as tumor markers in glioma. The gene discussed is MGMT; the disease is central nervous system cancer.